首页> 外文期刊>Journal of Internal Medicine >Family history of colorectal cancer and survival: a Swedish population‐based study
【24h】

Family history of colorectal cancer and survival: a Swedish population‐based study

机译:结直肠癌和生存的家族史:瑞典人口的研究

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Objectives A family history of colorectal cancer (CRC) is an established risk factor for developing CRC, whilst the impact of family history on prognosis is unclear. The present study assessed the association between family history and prognosis and, based on current evidence, explored whether this association was modified by age at diagnosis. Methods Using data from the Swedish Colorectal Cancer Registry (SCRCR) linked with the Multigeneration Register and the National Cancer Register, we identified 31?801 patients with a CRC diagnosed between 2007 and 2016. The SCRCR is a clinically rich database which includes information on the cancer stage, grade, location, treatment, complications and postoperative follow‐up. Results We estimated excess mortality rate ratios (EMRR) for relative survival and hazard ratios (HR) for disease‐free survival with 95% confidence intervals (CIs) using flexible parametric models. We found no association between family history and relative survival (EMRR?=?0.96, 95% CIs: 0.89–1.03, P ?=?0.21) or disease‐free survival (HR?=?0.98, 95% CIs: 0.91–1.06, P ?=?0.64). However, age was found to modify the impact of family history on prognosis. Young patients (50 at diagnosis) with a positive family history had less advanced (i.e. stages I and II) cancers than those with no family history (OR?=?0.71, 95% CI: 0.56–0.89, P ?=?0.004) and lower excess mortality even after adjusting for cancer stage (EMMR?=?0.63, 95% CIs: 0.47–0.84, P ?=?0.002). Conclusions Our results suggest that young individuals with a family history of CRC may have greater health awareness, attend opportunistic screening and adopt lifestyle changes, leading to earlier diagnosis and better prognosis.
机译:摘要目标结直肠癌(CRC)的家族史是制定CRC的既定危险因素,同时家庭史对预后的影响尚不清楚。本研究评估了家族史和预后之间的关联,并根据当前证据,探讨该协会是否按年龄修改诊断。方法使用来自瑞典结肠直肠癌注册表(SCRCR)的数据与多粒寄存器和国家癌症登记册有关,我们确定了31例CRC诊断的CRC患者2007年至2016年。SCRCR是一个临床丰富的数据库,包括有关的信息癌症阶段,等级,地点,治疗,并发症和术后随访。结果估计具有95%置信区间(CIS)的无病生存率的相对存活率和危害比(HR)的过度死亡率比(EMRR),采用柔性参数模型。我们发现家族史和相对生存之间没有关联(EMRR?= 0.96,95%CIS:0.89-1.03,P?=?0.21)或无病生存(HR?= 0.98,95%CIS:0.91-1.06 ,p?= 0.64)。但是,发现年龄修改家族史对预后的影响。患有阳性家庭历史的幼体患者(诊断)的癌症较少(即阶段I和II)癌,而不是没有家族史的癌症(或?=?0.71,95%CI:0.56-0.89,P?=?甚至在调整癌症阶段后,甚至在调整癌症阶段(EMMR?= 0.63,95%:0.47-0.84,P?0.002)即使在调整后,也较少过量的死亡率。结论我们的结果表明,与CRC家族历史的年轻人可能有更大的健康意识,参加机会主义筛查并采用生活方式的变化,导致早期的诊断和更好的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号